{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:21:38Z","timestamp":1785831698437,"version":"3.56.0"},"reference-count":10,"publisher":"Centers for Disease Control MMWR Office","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7139a2","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T14:57:16Z","timestamp":1664463436000},"page":"1235-1238","source":"Crossref","is-referenced-by-count":49,"title":["Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents \u2014 19 States, March 29\u2013July 25, 2022"],"prefix":"10.15585","volume":"71","author":[{"given":"Kevin W.","family":"McConeghy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Blackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Santostefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoojin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Canaday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Jernigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Pilishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Mor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gravenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"key-10.15585\/mmwr.mm7139a2-202209291047-R1","unstructured":"Centers for Medicare & Medicaid Services. COVID-19 nursing home data. Baltimore, MD: US Department of Health and Human Services, Centers for Medicare & Medicaid Services; 2022. Accessed September 4, 2022. https:\/\/data.cms.gov\/covid-19\/covid-19-nursing-home-data"},{"key":"key-10.15585\/mmwr.mm7139a2-202209291047-R2","unstructured":"CDC. Use of COVID-19 vaccines in the United States. Interim clinical considerations. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. Accessed August 31, 2022. https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html#primary-series"},{"key":"key-10.15585\/mmwr.mm7139a2-202209291047-R3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.15585\/mmwr.mm7118a4","article-title":"Effectiveness of a COVID-19 additional primary or booster vaccine dose in preventing SARS-CoV-2 infection among nursing home residents during widespread circulation of the Omicron variant\u2014United States, February 14\u2013March 27, 2022.","volume":"71","author":"Prasad","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7139a2-202209291047-R4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10654-017-0287-2","article-title":"The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening.","volume":"32","author":"Garc\u00eda-Alb\u00e9niz","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"key-10.15585\/mmwr.mm7139a2-202209291047-R5","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available.","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.mm7139a2-202209291047-R6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"key-10.15585\/mmwr.mm7139a2-202209291047-R7","unstructured":"CDC. Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/nursing-homes-antigen-testing.html"},{"key":"key-10.15585\/mmwr.mm7139a2-202209291047-R8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jamainternmed.2022.2658","article-title":"Association of receipt of the fourth BNT162b2 dose with Omicron infection and COVID-19 hospitalizations among residents of long-term care facilities.","volume":"182","author":"Muhsen","year":"2022","journal-title":"JAMA Intern Med"},{"key":"key-10.15585\/mmwr.mm7139a2-202209291047-R9","doi-asserted-by":"publisher","first-page":"e071502","DOI":"10.1136\/bmj-2022-071502","article-title":"Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study.","volume":"378","author":"Grewal","year":"2022","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.mm7139a2-202209291047-R10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.15585\/mmwr.mm7129e1","article-title":"Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA.1 and BA.2\/BA.2.12.1 sublineages predominated\u2014VISION Network, 10 states, December 2021\u2013June 2022.","volume":"71","author":"Link-Gelles","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T14:57:21Z","timestamp":1664463441000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7139a2.htm?s_cid=mm7139a2_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":10,"journal-issue":{"issue":"39","published-online":{"date-parts":[[2022,9,30]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7139a2","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,30]]},"published":{"date-parts":[[2022,9,30]]}}}